#+OPTIONS: toc:nil
#+latex_header: \usepackage{tabularx}
#+latex_header: \usepackage{booktabs}
#+latex_header: \usepackage[margin=9mm]{geometry}

#+ATTR_LATEX: :environment tabularx :width \textwidth :align XX

| Forme héréditaire de cancer                                | Gène         | Name                                       |
|------------------------------------------------------------+--------------+--------------------------------------------|
| I. Activation constitutive de la cascade de transduction   |              |                                            |
|------------------------------------------------------------+--------------+--------------------------------------------|
| Cancer médullaire de la thyroïde (CMT)                     | RET          | REarranged during Transfection             |
| Cancer papillaire du rein                                  | MET          | Mesenchymal Epithelial Transition          |
| Maladie de Cowden                                          | PTEN         | Phosphatase and TENsin homolog,            |
| Maladie de Von Hippel Lindau                               | VHL          | idem                                       |
| Médulloblastome                                            | SUFU         | Suppressor Of Fused Homolog (hedgehog !)   |
| Neurofibromatose de type I                                 | NF1          | idem                                       |
| Polypose adénomateuse familiale                            | APC          | Adenomatous Polyposis coli                 |
| Syndrome de Gorlin                                         | PTCH         | PaTCH                                      |
| Tumeur de Wilms                                            | WT1          | Wil's Tumor                                |
|------------------------------------------------------------+--------------+--------------------------------------------|
| II. Altération des points de contrôles du cycle cellulaire |              |                                            |
|------------------------------------------------------------+--------------+--------------------------------------------|
| Rétinoblastome                                             | RB1          | idem                                       |
| Mélanome malin                                             | CDKN2A       | Cyclin Dependent Kinase Inhibitor          |
| Syndrome de Li-Fraumeni                                    | TP53         | Tumor Protein                              |
|------------------------------------------------------------+--------------+--------------------------------------------|
| III. Altération des systèmes de réparation de l'ADN        |              |                                            |
|------------------------------------------------------------+--------------+--------------------------------------------|
| Cancer du sein et de l'ovaire                              | BRCA1, BRCA2 | BReast CAncer                              |
| Polypose adénomateuse autosomique récessive                | MUTYH        | Mut Y DNA glycosylase                      |
|                                                            | MLH1         | MuLt Homolog                               |
| Syndrome de Lynch                                          | MSH          | DNA repair MiSmatcH                        |
| Xeroderma pigmentosum                                      | XP           | idem                                       |
|------------------------------------------------------------+--------------+--------------------------------------------|
| Autres                                                     |              |                                            |
|------------------------------------------------------------+--------------+--------------------------------------------|
| Cancers bronchiques                                        | ALK          | Activin receptor-Like Kinase 1             |
| Carcinomes colique, bronchiques                            | KRAS         | Kirsten RAt Sarcoma viral oncogene homolog |
| Carcinomes sein, ovaire                                    | HER2         | Human Epidermal growth factor Receptor 2   |
| Carcinomes+++, gliomes                                     | EGFR         | Epidermal Growth Factor Receptor           |
| GastroIntestinal STromal Tumor                             | KIT          |                                            |
| Leucémies aigües myéloïdes                                 | FLT3         | Fms-Like Tyrosine kinase 3                 |
| Leucémies, mélanomes                                       | NRAS         | Neuroblastoma-RAS                          |
| Lymphome de Burkitt                                        | C-MYC        | Cellular MYeloCytomatosis                  |
| Lymphomes du manteau                                       | Cycline D    |                                            |
| Mélanome                                                   | CD4          | Cluster of differentiation 4               |
| Mélanomes                                                  | BRAF         |                                            |
| Neuroblastomes                                             | N-MYC        |                                            |
| Sarcomes, gliomes                                          | PDGFR        | Platelet-derived growth factor receptors   |
